The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN FR RO RU |
| Publicado: |
Asociatia de Biosiguranta si Biosecuritate
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/6662844190594fddbe05c29baf17225b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|